NCT05301920View on ClinicalTrials.gov

The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

January 28, 2022

Study Completion Date

January 28, 2022

Conditions
Migraine
Interventions
DEVICE

Elexir (trigeminal nerve electrical stimulator)

Elexir performs a personal electrical stimulation around the trigeminal nerves for 4weeks (6 times/week), 20 minutes each time.

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Nu Eyne Co., Ltd.

INDUSTRY

NCT05301920 - The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Migraine | Biotech Hunter | Biotech Hunter